Neuro-Oncology: The Podcast

76 Episodes

1. Changes in survival outcomes in melanoma patients with brain metastases

   Published: 4/21/2023
2. Radiation therapy and structural brain changes

   Published: 4/7/2023
3. Objective response rate targets for recurrent glioblastoma clinical trials

   Published: 3/17/2023
4. Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era

   Published: 3/3/2023
5. Palliative care in neuro-oncology

   Published: 2/10/2023
6. Nivolumab in MGMT methylated GBM

   Published: 1/27/2023
7. IDH mutant gliomas; SNO consensus Review

   Published: 1/13/2023
8. DNA methylation subclass and extent of GBM resection

   Published: 12/30/2022
9. Pre-operative [11C]methionine PET for low-grade glioma

   Published: 12/16/2022
10. The role of T lymphocytes in the glioma pathobiology

    Published: 12/2/2022
11. CDKN2A homozygous deletion in IDH mutant astrocytoma

    Published: 10/8/2022
12. EGFR: the lazarus target in glioblastom

    Published: 9/23/2022
13. Brain metastases; a SNO consensus review: Part 2

    Published: 9/9/2022
14. Brain metastases; a SNO consensus review: Part 1

    Published: 8/26/2022
15. Pediatric IDH mutant gliomas

    Published: 8/13/2022
16. Low-risk meningioma: Outcomes from NRG 0539

    Published: 7/29/2022
17. Selumetinib in children with NF1 and plexiform neurofibroma

    Published: 7/1/2022
18. Targeted therapy for BRAF-mutant pediatric glioma

    Published: 6/17/2022
19. Early/evolving IDH wild-type glioblastoma

    Published: 5/20/2022
20. PI3K signaling in IDH mutant gliomas

    Published: 5/6/2022